Current stock page

Financial Data

NTRA Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - Diagnostics & ResearchScore data as of Sep 4, 2026

NTRA

Financial Data
Natera, Inc.
Healthcare· Medical - Diagnostics & Research
AIQ Score
NeutralAIQ Edge 5/10
Low Priority
In Line With Peers
Score data as of Sep 4, 2026
Last price
$328.18
+$0.51 (+0.16%)
Latest market quote
Momentum63
Value34
Quality57
Risk Resilience63
Sentiment75
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 5, 2026.

Income statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue$752.75M$696.64M$665.5M$592.18M$546.6M$501.83M$476.06M$439.76M
Gross Profit$485.19M$451.44M$446.82M$384.38M$347.07M$317.22M$299.64M$271.75M
Operating Income
Net Income-$66.97M-$85.09M$47.26M-$87.54M-$100.94M-$66.94M-$53.77M-$31.59M
EPS-$0.47-$0.6$0.35-$0.64-$0.74-$0.5-$0.41-$0.26
Cash flow statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Operating Cash Flow$54.79M$40.17M$73.89M$59.39M$37.57M$44.45M$52.89M$51.79M
Capital Expenditure-$63.43M-$22.14M-$36.07M-$34.91M-$25.9M-$21.82M-$18.12M-$16.31M
Free Cash Flow-$8.64M$18.03M$37.82M$24.48M$11.68M$22.64M$34.77M$35.47M
Net Cash Provided By Operating Activities$54.79M$40.17M$73.89M$59.39M$37.57M$44.45M$52.89M$51.79M
Balance sheet
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Assets$2.66B$2.61B$2.51B$1.82B$1.76B$1.73B$1.66B$1.59B
Total Debt$238.49M$240.08M$214.38M$184.72M$196.14M$195.6M$187.12M$475.73M
Cash And Cash Equivalents
Total Liabilities$836M$840.38M$795.62M$569.29M$510.88M$492.69M$465.32M$712.42M
Total Stockholders Equity$1.82B$1.77B$1.71B$1.25B$1.25B$1.24B$1.2B$878.53M
Key financial metrics
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio-144.39-83.33163.64-63.06-57.07-71.17-91.79-124.35
P/B ratio21.3515.9518.2917.6418.4915.3716.5217.89
P/S ratio51.6740.6247.0637.2942.1537.9741.4735.73
Debt To Equity0.130.140.130.150.160.160.160.54
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio
P/B ratio21.3515.9518.2917.6418.4915.3716.5217.89
P/S ratio51.6740.6247.0637.2942.1537.9741.4735.73
Return On Equity-3.68%-4.80%2.76%-6.99%-8.10%-5.40%-4.50%-3.60%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
-235.85
multipleSep 4, 2026
Pb
25.23
multipleSep 4, 2026
Revenue Growth Yoy
8.05
percentSep 4, 2026
EPS Growth Yoy
21.67
percentSep 4, 2026
Gross Margin
65.3
percentSep 4, 2026
Operating Margin
-10.7
percentSep 4, 2026
ROE
-11.73
percentSep 4, 2026
ROIC
-10.02
percentSep 4, 2026
Debt To Equity
0.13
ratioSep 4, 2026
FCF Yield
0.16
percentSep 4, 2026
Technical indicators
Close
328.18
priceSep 4, 2026
Volume
968,221
volumeSep 4, 2026
Rsi14
60.95
indexSep 4, 2026
MACD
11.82
indexSep 4, 2026
MACD Signal
14.05
indexSep 4, 2026
MACD Histogram
-2.22
indexSep 4, 2026
Adx14
38.16
indexSep 4, 2026
Sma50
292.27
priceSep 4, 2026
Sma200
235.65
priceSep 4, 2026
Atr14
11.26
priceSep 4, 2026
Historical Volatility
0.29
percentSep 4, 2026
Volume Ma20
1,274,711.25
volumeSep 4, 2026
Risk measures
Resilience Score
63
score_0_100Sep 4, 2026
Beta
1.51
ratioSep 4, 2026
Volatility Annual
48.3
percentSep 4, 2026
Max Drawdown
-28.2
percentSep 4, 2026
Sharpe Ratio
1.57
ratioSep 4, 2026
Var95
-3.78
percentSep 4, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

NTRA Financial Data FAQ

What is Natera, Inc.'s revenue?

Natera, Inc.'s revenue is one of the core financial data points for NTRA. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Natera, Inc.'s revenue growing?

Revenue growth shows whether Natera, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is NTRA's EPS?

NTRA's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Natera, Inc.'s net income?

Natera, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Natera, Inc. generate?

Free cash flow shows how much cash Natera, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Natera, Inc. have?

Cash and debt help frame NTRA's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.